Published studies have explored BPC-157 in relation to: tendon repair ligament healing skeletal muscle biology joint and connective tissue research angiogenesis gastrointestinal protection inflammatory signalling nitric oxide pathways peripheral nerve research soft-tissue regeneration Because tendon, ligament and muscle injuries are common in physically active populations, BPC-157 has also become one of the most recognised peptides in sports medicine and musculoskeletal recovery research , although the majority of published evidence remains preclinical
It now sits within a growing gray-market peptide ecosystem that includes compounds such as BPC-157 (marketed for healing and recovery), TB-500 (muscle repair), KPV (anti-inflammatory use), MOTS-c (metabolic performance), Epitalon (anti-aging), Semax (cognitive enhancement), DSIP (sleep and recovery), and Melanotan II itself, despite limited clinical evidence and lack of regulatory approval
It is contraindicated in pregnancy and breastfeeding, can cause significant irritation, and increases photosensitivity
DSIP had no effect on somatotrope and corticotrope differentiation